Literature DB >> 11157347

Quality assurance criteria for probiotic bacteria.

E Tuomola1, R Crittenden, M Playne, E Isolauri, S Salminen.   

Abstract

Acid and bile stability and intestinal mucosal adhesion properties are among the criteria used to select probiotic microbes. The quality control of probiotic cultures in foods traditionally has relied solely on tests to ensure that an adequate number of viable bacteria are present in the products throughout their shelf lives. Viability is an important factor, but not the only criterion for quality assurance. To be effective, probiotic strains must retain the functional health characteristics for which they were originally selected. Such characteristics include the ability to survive transit through the stomach and small intestine and to colonize the human gastrointestinal tract. In vitro test protocols can be readily adopted to examine the maintenance of a strain's ability to tolerate acidic conditions, survive and grow in the presence of bile, and metabolize selective substrates. Molecular techniques are also available to examine strain stability. Adhesion characterization may be an important quality-control method for assessing gut barrier effects. Adhesion has been related to shortening the duration of diarrhea, immunogenic effects, competitive exclusion, and other health effects. Adhesion properties should be carefully monitored, including adhesion to intestinal cells (eg, Caco-2) and human intestinal mucus. This article outlines the types of in vitro testing that can be used to ensure quality control of functional probiotic strains.

Entities:  

Mesh:

Year:  2001        PMID: 11157347     DOI: 10.1093/ajcn/73.2.393s

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  70 in total

1.  Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407.

Authors:  Chang Liu; Zhuo-Yang Zhang; Ke Dong; Xiao-Kui Guo
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Like mother, like microbe: human milk oligosaccharide mediated microbiome symbiosis.

Authors:  Schuyler A Chambers; Steven D Townsend
Journal:  Biochem Soc Trans       Date:  2020-06-30       Impact factor: 5.407

3.  Survival, Intestinal Mucosa Adhesion, and Immunomodulatory Potential of Lactobacillus plantarum Strains.

Authors:  Valentini Santarmaki; Yiannis Kourkoutas; Georgia Zoumpopoulou; Eleni Mavrogonatou; Mikis Kiourtzidis; Nikos Chorianopoulos; Chrysoula Tassou; Effie Tsakalidou; Constantinos Simopoulos; Petros Ypsilantis
Journal:  Curr Microbiol       Date:  2017-06-21       Impact factor: 2.188

4.  Semi-industrial Scale Production of a New Yeast with Probiotic Traits, Cryptococcus sp. YMHS, Isolated from the Red Sea.

Authors:  Ashraf F El-Baz; Hesham A El-Enshasy; Yousseria M Shetaia; Hoda Mahrous; Nor Zalina Othman; Ahmed E Yousef
Journal:  Probiotics Antimicrob Proteins       Date:  2018-03       Impact factor: 4.609

Review 5.  Bile salt hydrolase activity in probiotics.

Authors:  Máire Begley; Colin Hill; Cormac G M Gahan
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

Review 6.  Genes and molecules of lactobacilli supporting probiotic action.

Authors:  Sarah Lebeer; Jos Vanderleyden; Sigrid C J De Keersmaecker
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

7.  Antioxidant lactobacilli could protect gingival fibroblasts against hydrogen peroxide: a preliminary in vitro study.

Authors:  Ayşegül Mendi; Belma Aslım
Journal:  Probiotics Antimicrob Proteins       Date:  2014-12       Impact factor: 4.609

8.  Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications.

Authors:  M Medina; E Izquierdo; S Ennahar; Y Sanz
Journal:  Clin Exp Immunol       Date:  2007-10-22       Impact factor: 4.330

9.  Functional and probiotic attributes of an indigenous isolate of Lactobacillus plantarum.

Authors:  Jai K Kaushik; Ashutosh Kumar; Raj K Duary; Ashok K Mohanty; Sunita Grover; Virender K Batish
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

10.  Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial.

Authors:  David R Mandel; Katy Eichas; Judith Holmes
Journal:  BMC Complement Altern Med       Date:  2010-01-12       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.